http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111233963-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J63-008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7024 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J63-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7024 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2020-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111233963-B |
| titleOfInvention | Active monomer for treating esophageal cancer, and composition and application thereof |
| abstract | The invention discloses an active monomer for treating esophageal cancer, a composition and an application thereof, and adopts the technical scheme that a cell model is used, activity tracking is taken as a guide, modern extraction and separation technologies such as alcohol extraction, chromatography, high performance liquid chromatography and the like are adopted, the active monomer is respectively extracted from two traditional Chinese medicines of fructus gleditsiae and rhizoma bolbostemmae with anticancer activity, the molecular composition is deduced by using a chemical spectrogram means, the molecular structure of each monomer is determined, the dosage proportion of the monomers is determined by a base line equal-proportion subtraction method, the composition for treating esophageal cancer is combined, and then the active monomer and the composition act on various esophageal cancer cells to study the action mechanism of the cells on the esophageal cancer. The two active monomers and the composition thereof provided by the invention are both extracted from natural medicines, belong to pure Chinese medicinal preparations, have the effects of preventing and treating esophageal cancer, and have great market potential and wide market application prospect. |
| priorityDate | 2020-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 112.